In the 29 tumors with viral integration a total of 37 fusion products were identified, of which 10 harbored cellular sequences corresponding to intergenic regions and 27 to known or predicted genes, including 12 tumor-related genes (BCL2, BRE, EPHA7, FANCC (2×), HDAC2, INO80C, LEPREL1, SYNPO2, TP63, TRAF3, TUBD1), 5 genes involved in deregulated tumor-related pathways (ERC2, GARS, SLC7A1, SYN3, ZMAT4), and 10 genes with no known role in tumorigenesis. Here, TP63 is linked to neoplasm.